Clinical Trials ReportProgress and pitfalls with IBD serologies

被引:0
|
作者
Joseph H. Sellin
机构
关键词
Ulcerative Colitis; Capsule Endoscopy; Saccharo; Unaffected Relative; Outer Membrane Porin;
D O I
10.1007/s11894-006-0018-4
中图分类号
学科分类号
摘要
Anti-OMPC may be a familial trait in CD. This finding reflects a general but not entirely consistent body of literature indicating that IBD serologic patterns may run in families. This implies that anti-OMPC may serve as an immunologic risk marker for IBD and may represent a genetic susceptibility for CD. If genetically determined immunophenotypes are found to lead to IBD, an important insight into the etiology and pathophysiology of the disease may follow.
引用
收藏
页码:351 / 352
页数:1
相关论文
共 50 条
  • [1] State of the art: IBD therapy and clinical trials in IBD
    Isaacs, KL
    Lewis, JD
    Sandborn, WJ
    Sands, BE
    Targan, SR
    INFLAMMATORY BOWEL DISEASES, 2005, 11 : S3 - S12
  • [2] Clinical trials in IBD: A pediatric perspective
    Kirschner, BS
    Ferry, GD
    INFLAMMATORY BOWEL DISEASES, 1996, 2 (02) : 118 - 120
  • [3] The promise and pitfalls of clinical trials overseas
    Normile, Dennis
    SCIENCE, 2008, 322 (5899) : 214 - 216
  • [4] Clinical trials in children: Problems and pitfalls
    Kauffman R.E.
    Paediatric Drugs, 2000, 2 (6): : 411 - 418
  • [5] Pitfalls of statistics in clinical trials design
    Gray, S
    MEDICAL TEXTILES, 2001, : 217 - 224
  • [6] The Power and the Pitfalls of Randomized Clinical Trials
    Sundt, Thoralf M.
    ANNALS OF THORACIC SURGERY, 2021, 111 (02): : 699 - 700
  • [7] Evolution of IBD Serologies Over Time in 3 Pediatric Patients
    Abell, Rebecca
    Morganstern, Jeffrey
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S69 - S69
  • [8] Current Issues in the Design of Clinical Trials in IBD
    Feagan, Brian G.
    NUTRITION, GUT MICROBIOTA AND IMMUNITY: THERAPEUTIC TARGETS FOR IBD, 2014, 79 : 19 - 28
  • [9] Design issues and outcomes in IBD clinical trials
    Sands, BE
    Abreu, MT
    Ferry, GD
    Griffiths, AM
    Hanauer, SB
    Isaacs, KL
    Lewis, JD
    Sandborn, WJ
    Steinhart, AH
    INFLAMMATORY BOWEL DISEASES, 2005, 11 : S22 - S28
  • [10] Design of clinical trials in sepsis: problems and pitfalls
    Finch, RG
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 : 95 - 102